Authors : Tadikonda Rama Rao; Jadhav Bharath

Volume/Issue : Volume 9 - 2024, Issue 8 - August

Google Scholar : https://tinyurl.com/mux55vn2

Scribd : https://tinyurl.com/4atnfezb

DOI : https://doi.org/10.38124/ijisrt/IJISRT24AUG544

Abstract : The current study examines the creation of UV Spectrophotometric technique for metronidazole. Metronidazole in tablet dosage form can now be estimated using an easy to use, precise and economical spectrophotometric approach. The ideal circumstances were determined for medication analysis. It was discovered that 275 nm was the maximum wavelength (λmax). Metronidazole percentage recovery fell between 98-102%. In the 5-40 μg/ml concentration range, beers law followed. A true correlation between optical density and intensity can be seen in calibration curve. Linearity, accuracy, precision, LOD, and LOQ were all validated in accordance with ICH requirements.

Keywords : UV Determination, Method Development, Validation, Metronidazole.

References :

1. Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.  Clin Pharmacokinetic. 1999; 36(5): 353–373.
2. Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections.  Expert Opine Pharmacotherapy. 2015; 16(7): 1109–1115.
3. Pasupuleti V, Escobedo AA, Deshpande A, Thota P, Roman Y, Hernandez AV.  Efficacy of 5 nitroimidazoles for the treatment of giardiasis:  a systematic review of randomized controlled trials. PLoS Negl Trop Dis. 2014; 8(3): e2733. 
4. Thulkar J, Kriplani A, Agarwal N.  A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.  Indian J Pharmacol. 2012; 44(2): 243–245. 
5. Brook I. Spectrum and treatment of anaerobic infections. J Infect Che mother. 2016; 22(1): 1–13.
6. Jarrad AM, Debnath A, Miyamoto Y, Han’s ford KA, Pelingon R, Butler MS, Bains T, Karoli T, Blaskovich MA, Eckmann L, Cooper MA.  Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. Eur J Med Chem. 2016; 120: 353–362.
7. Castelli M, Malagoli M, Ruberto AI, Baggio A, Caso-lari C, Cermelli C, Bossa MR, Rossi T, Paolucci F, Roffia S. In-vitro studies of two 5-nitroimidazole derivatives. J Antimicrobe Chemother.  1997; 40(1): 19–25.
8. Mandalapu D, Kushwaha B, Gupta S, Singh N, Shukla M, Kumar J,  Tanpula  DK,  Sankhwar  SN, Maikhuri JP, Siddiqi MI, Lal J, Gupta G, Sharma VL. 2-Methyl-4/5-nitroimidazole derivatives potentiated against sexually transmitted Trichomonas:  Design, synthesis, biology and 3D-QSAR study.  Eur J Med Chem. 2016; 124: 820–839. 
9. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbial Rev. 2001; 14(1): 150–164.
10. Church DL, Rabin HR, Laishley EJ. Reduction of 2, 4- and 5-nitroimidazole drugs by hydrogenase 1 in Clostridium Pasteurian.  J Antimicrobe Chemother. 1990; 25(1): 15–23.
11. Kedderis GL, Argenbright LS, Miwa GT.  Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation. Chem Res Toxicol. 1989; 2(3): 146–149.
12. Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity a systematic review.  Clin Neuropharmacology.  2011; 34(6): 241–247.
13. Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, Marselos M. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. Int J Toxicol. 2007; 26(5): 423–432.
14. Noureldin M, Krause J, Jin L, Ng V, Tran M. Drug-Alcohol Interactions: A Review of Three Therapeutic Classes. US Pharm. 2010; 35(11): 29–40.  
15. Edwards DI. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs. Br J Vener Dis. 1980; 56(5): 285–290.
16. Moreno SN, Docampo R.  Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.  Environ Health Prospect.  1985; 64:  199–208.
17. Jang GR, Harris RZ. Drug interactions involving ethanol and alcoholic beverages.  Expert Opin Drug Metab Toxicol. 2007; 3(5): 719–731.
18. Fjeld H, Raknes G. [Is combining metronidazole and alcohol really hazardous?]. Tidsskr Nor Laegeforen. 2014; 134(17): 1661–1663. [Article in Norwegian]
19. Nagaraja P, Sunitha K R, Vasantha R A, Yathirajan H S. Spectrophotometric determination of metronidazole and tinidazole in pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis.2002;28(3):527-535.
20. Jadhav G P, More H N, Mahadik K R. Simultaneous UV-Spectrophotometric estimation of Nalidixic acid and Metronidazole. Indian Journal of Pharmaceutical science.1998; 60: 246-248.
21. Maliwal D, Jain A, Maheswari R K. Simultaneous UV-Spectrophotometric estimation of Norfloxacin and Metronidazole. Asian Journal of Pharmaceutics. 2008; 4 (5); 1-7.
22. Ravishankar S, Vasudevan M, Nanjan M J. RP-HPLC method for estimation of Metronidazole. 1998;35: 359-363.
23. Tashtoush B M, Jacobson E L, Jacobson M K. Validation of a simple and rapid HPLC method for determination of metronidazole in dermatological formulations. Drug Dev IndPharm.2008;34(8): 840-844.
24. Sebai M M, El-ShanawanyA A, El-Adl S M, Abdel-Aziz L M, Hashem H A. Rapid RP-HPLC method for simultaneous estimation of sparfloxacin, gatifloxacin, metronidazole and tinidazole. Asian Journal of Pharmaceutical Research.2011;1(4): 119-125.
25. Wei Zeng, Donald Musson G, Alison Fisher L, Li Chen, Michael Schwartz S, Eric Woolf J, Amy Qiu Wang. Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometry. J Pharm Biomed Anal. 2008; 46(3):534-542.
26. Xiong Y, Zhou HJ, Zhang ZJ. A chemiluminescence sensor for determination of metformin in urine samples based on molecularly imprinted polymer. FenxiShiyanshi. 2006;25(3):5.
27. Zeng W, Xu Y, Constanzer M, Woolf EJ. Determination of sitagliptinin human plasma using protein precipitation and tandem mass spectrometry. J Chromatogr B. 2010; 878(21):1817-1823.